GM-CSF priming of human monocytes is dependent on ERK1/2 activation

Journal of Endotoxin Research

Volumn 12, Issue 1, 2006, Pages 10-20

  Lendemans, Sven ^a   Rani, Meenakshi ^a   Selbach, Christian ^a   Kreuzfelder, Ernst ^a   Schade, Fritz Ulrich ^a   Flohé, Sascha ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Cytokines; GM CSF; Lipopolysaccharide; Monocytes; Signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CALPHOSTIN C; GENISTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOXYGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MOLGRAMOSTIN; NORDIHYDROGUAIARETIC ACID; PROTEIN P50; PROTEIN TYROSINE KINASE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STAUROSPORINE; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LEUKOCYTE FUNCTION; MONOCYTE; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTIGENS, CD14; BLOTTING, WESTERN; CELL NUCLEUS; CELL SURVIVAL; CYTOPLASM; EIF-2 KINASE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME ACTIVATION; ENZYME INHIBITORS; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; I-KAPPA B PROTEINS; LIPOPOLYSACCHARIDES; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; NF-KAPPA B; PHOSPHORYLATION; STIMULATION, CHEMICAL; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 31644438559     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805106X89107     Document Type: Article

References (29)

1. Doecke WD, Randow F, Syrbe U et al. Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat Med 1997; 3: 678-681.
2. Williams MA, Withington S, Newland AC, Kelsey SM. Monocyte anergy in septic patients is associated with a predilection to apoptosis and is reversed by GM-CSF ex vivo. J Infect Dis 1998; 178: 1421-1433.
3. Fischer HG, Frosch S, Reske K, Reske-Kunz AB. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHCII molecules and to augment antigen presentation function. J Immunol 1988; 141: 3882-3888.
4. Hayes MP, Zoon KC. Priming of human monocytes for enhanced lipopolysaccharide responses: expression of alpha interferon, interferon regulatory factors, and tumor necrosis factor. Infect Inunun 1993; 61: 3222-3227.
5. Hayes MP, Wang J, Norcross MA. Regulation of interieukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p4O genes. Blood 1995; 86: 646-650.
6. Sisson SD, Dinarello CA. Production of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor. Blood 1988; 72: 1368-1374.
7. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1: 135-145.
8. McLeish KR, Knall C, Ward RA et al. Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF. J Leukoc Biol 1998; 64: 537-545.
9. Salh B, Hoeflick K, Kwan W, Pelech S. Granulocyte-macrophage colony-stimulating factor and interleukin-3 potentiate interferon-gamma-mediated endothelin production by human monocytes: role of protein kinase C. Immunology 1998; 95: 473-479.
10. Sibelius U, Hattar K, Hoffmann S et al. Distinct pathways of lipopolysaccharide priming of human neutrophil respiratory burst: role of lipid mediator synthesis and sensitivity to interleukin-10. Crit Care Med 2002; 30: 2306-2312.
11. Flohé S, Boergermann J, Dominguez FE et al. Influence of granulocyte-macrophage colony-stimulating factor (GM-CSF) on whole blood endotoxin responsiveness following trauma, cardiopulmonary bypass, and severe sepsis. Shock 1999; 12: 17-24.
12. Lu J, Lucas R, Schuchmann M et al. GM-CSF restores innate, but not adaptive, immune response in glucocorticoid-inummosuppressed human blood in vitro. J Immunol 2003; 171: 938-947.
13. Nierhaus A, Montag B, Timmler N et al. Reversal of immunoparalysis by recombinant human GM-CSF in patients with severe sepsis. Intensive Care Med 2003; 29: 646-651.
14. Hayes MP, Enterline JC, Gerrard TL, Zoon KC. Regulation of interferon production by human monocytes: requirements for priming for lipopolysaccharide-induced production. J Leukoc Biol 1991; 50: 176-181.
15. Randow F, Doecke WD, Bundschuh DS, Hartung T, Wendel A, Volk HD. In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and gramilocyte-macrophage colony-stimulating factor. J Immunol 1997; 158: 2911-2918.
16. Kurt-Jones EA, Mandell L, Whitney C et al. Role of Toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated IL-8 response in neutrophils. Blood 2002; 100: 1860-1868.
17. Adib-Conquy B, Cavaillon JM. Gamma interferon and GM-CSF prevent endotoxin tolerance in human monocytes by promoting interleukin- 1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression. J Biol Chem 2002; 227: 27927-27934.
18. de Groot RP, Coffer PJ, Koenderman L. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell Signal 1998; 10: 619-628.
19. Dang PM, Fontayne A, Hakim J, FJ Benna J, Perianin A. Protein kinase C zeta phosphorylates a subset of selective sites of the NADPH oxidase component p47phox and participates in formyl peptide-mediated neutrophil respiratory burst. J Immunol 2001; 166: 1206-1213.
20. Nagata M, Sedgwick JB, Busse WW. Differential effects of granulocyte-macrophage colony-stimulating factor on eosinophil and neutrophil superoxide anion generation. J Immunol 1995; 155: 4948-4954.
21. Palmantier R, Surette ME, Sanchez A, Braquet P, Borgeat R Priming for the synthesis of 5-lipoxygenase products in human blood ex vivo by human granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Lab Invest 1994; 70: 696-704.
22. Carter AB, Knudtson KL, Monick MM, Hunninghake GW. The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP). J Biol Chem 1999; 274: 30858-30863.
23. Rutault K, Hazzalin CA, Mahadevan LC. Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-alpha) mRNA induction. Evidence for selective destabilization of TNF-alpha tratiscripts. J Biol Chem 2001; 276: 6666-6674.
24. Van Hilten JA, Elliott GR, Bonta IL Specific lipoxygenase inhibition reverses macrophage cytotasis towards P815 tumor cells in vitro induced by the calcium ionophore A23187. Prostaglandins Leukot Essent Fatty Acids 1988; 34: 187-192.
25. Carter AB, Monick MM, Hunninghake GW. Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol 1999; 20: 751-758.
26. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995; 270, 27489-27494.
27. Van der Bruggen, Nijenhuis S, Van Raaij E, Verhoef J, Van Asbeck BS. Lipopolysaccharide-induced TNF-α production by human monocytes involves raf-I/MEKI-MEK2/ERKI-ERK2 pathway. Infect Immun 1999; 67: 3824-3829.
28. Marin M, Liu Z, Zandi E AP- I function and regulation. Curr Opin Cell Biol 1997; 9: 240-246.
29. Means TK, Pavlovich RP, Roca D, Vermeulen MW, Fenton MJ. Activation of TNF-α transcription utilizes distinct MAP kinase pathways in different macrophage populations. J Leukoc Biol 2000; 67: 885-893.